Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model

scientific article published on 01 August 2003

Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1011242329
P356DOI10.1038/SJ.BMT.1704145
P698PubMed publication ID12900772

P2093author name stringNagler A
Ilan Y
Ohana M
Sherman Y
Engelhardt D
Alper R
Rabbani E
Doviner V
P2860cites workAllogeneic hematopoietic stem cell transplantation: complications and resultsQ30309645
Improving immune reconstitution while preventing graft-versus-host disease in allogeneic stem cell transplantationQ34499730
Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral toleranceQ36366774
Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectorsQ37364744
Cytokine inhibitors and graft-versus-host diseaseQ40967676
Graft-versus-host disease and the Th1/Th2 paradigmQ41062993
Graft-versus-host disease: implications from basic immunology for prophylaxis and treatment.Q41385441
Oral tolerance: immune mechanisms and treatment of autoimmune diseasesQ41546336
Cytokine cascades in acute graft-versus-host diseaseQ41592255
Immune responses to dietary antigens: oral tolerance.Q41759582
Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effectQ43824684
Suppressor function of liver mononuclear cells isolated during murine chronic graft-vs-host disease. II. Role of prostaglandins and interferon-gammaQ44479368
Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenovirusesQ45887065
Graft-versus-host diseaseQ68195420
Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa moleculesQ71700468
Cytokine dysregulation in chronic graft versus host diseaseQ72293272
Induction of oral tolerance towards hepatitis B envelope antigens in a murine modelQ73195291
Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in miceQ73520229
Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytesQ73674264
Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosisQ73677331
P433issue4
P304page(s)363-369
P577publication date2003-08-01
P1433published inBone Marrow TransplantationQ4941523
P1476titleInduction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model
P478volume32

Reverse relations

cites work (P2860)
Q81042784Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes
Q36399399Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease
Q46693820Keratinocyte growth factor ameliorates acute graft-versus-host disease in a novel nonmyeloablative haploidentical transplantation model
Q35847596New approaches for preventing and treating chronic graft-versus-host disease

Search more.